Skip to Main Content

Paper Details

The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.
Cancers (Basel)
39
2021
PATHFINDER, Participants, Plasma cfDNA, cancer, cancers, cell, cell-, cfDNA, multi, participants
Author NameAffiliation
Tomasz M BeerOregon Health & Science University Knight Cancer Institute
Minetta C LiuMayo Clinic
Eric A KleinGlickman Urological and Kidney Institute, Cleveland Clinic
Deborah SchragDana-Farber Cancer Institute
  • 1 - 4

Datasets

Release 1.2